ELSA 4.0 is live. Forty-plus systems consolidated.
The one-day inspection pilot has forty completions behind it and is expanding.
If you arrived here because that changed something for you — you're in the right place.
If you manufacture for the US market outside US borders — FDA's enforcement infrastructure reaches your facility. ELSA doesn't check your passport. It reads your data.
The Critical Path is not a newsletter.
Not coaching.
Not something designed to be forwarded internally.
It is a private briefing for operators who carry accountability for systems that must hold under scrutiny — written at the level of the decision, not the recommendation.
"A facility that needs regulatory choreography to pass inspection
has already failed the inspection."
Inspection pressure does not create failure.
It exposes systems that only worked because no one was looking.
By the time investigators arrive, three things are already true:
The architecture has spoken.
The signal history exists.
The ownership structure is visible.
The outcome was not decided during the inspection. It was decided when the system was designed — and confirmed every week a structural condition was left unresolved.
Most industry commentary explains what inspectors found.
Most remediation plans address what the 483 documented.
Neither changes the architecture that produced the outcome.
Neither addresses what the system was signaling — and what it was structurally incapable of answering — before anyone arrived.
Field-tested analysis of where GMP systems fail under inspection pressure — drawn from real operations under regulatory scrutiny.
Each Field Note examines a specific structural condition: ownership architecture, authority boundaries, signal handling, governance design. It documents why the failure repeats — across sites, companies, and inspection types — and what the system was producing before the finding made it visible.
The objective is singular:
Identify structural failure modes before inspection pressure does.
You carry accountability for systems that must hold under scrutiny — not just systems that have previously passed inspection.
If you have watched a system that appeared controlled produce an unexpected finding - this briefing documents the architecture that produced it.
If ownership questions surfaced during an inspection that should have been resolved six months earlier - this briefing explains why that pattern is structural, not situational.
If you are operating with zero margin for remediation and no tolerance for the answer "we're working on it" - this briefing is written at your level.
If this page feels familiar rather than instructive - that is the signal. It means you have already paid for the lesson.
The Critical Path is read privately by leaders preparing for Pre-Approval Inspections, inspections following scale-up, tech transfer, or M&A, and facilities operating under compressed launch timelines with no remediation runway.
It is used to pressure-test thinking.
Not to circulate internally.
Not to defend decisions already made.
Not to train teams.
If you are looking for something to forward to your quality organization, this is not it.
"A facility that needs regulatory choreography to pass inspection has already failed the inspection."
The Critical Path documents where these laws appear in real operations — before inspection exposes them.
Included
This list is private. Your information is never shared. Unsubscribe anytime.